Starling Oncology, Inc.
STLNW
Last
$0.03
Day
-1.0%
1y
—
5y
—
52w
—
SPY YTD
+13.3%
Sec
—
Earnings
—
EMA 21
—
EMA 50
—
EMA 200
—
20d high
—
5y high
—
5y range
—
Positions held
Your positionsSTLNW isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
—
Hold
—
Signal
—
Target
—
Stop
—
Stop distance
—
Target vs last
—
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | -0.16 | Beta | 0.42 | Dividend yield | — |
| Revenue growth | 34.6% | Earnings growth | — | Gross margin | 15.7% | Operating margin | -2.9% |
| Profit margin | -6.2% | ROE | — | ROA | -9.6% | Debt / equity | — |
| Current ratio | 1.36 | Free cash flow | $8.60M | Analyst recommendation | none | Mean target | — |
| 52w high | $0.04 | 52w low | $0.04 |
Quarterly
No data yet.
Yearly (6y)
No data yet.
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsNo price history yet for STLNW.